Some five years into a pneumococcal vaccine patent dispute in South Korea, SK Bioscience has emerged victorious over Pfizer.

Having already worked with clinical trial sites in more than 14 states, CTAC will now take its work nationwide, the ...

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, ...

SK bioscience wins patent lawsuit against Pfizer over pneumococcal vaccine in Korea: Gyeonggi-do, Republic of Korea Friday, May 23, 2025, 10:00 Hrs [IST] SK bioscience, a global i ...

Overview of RNA Therapeutics MarketThe Global RNA Therapeutics Market is valued at USD 10.9 Billion in 2024 and is projected ...

The Global Nanomedicine Market is expected to witness a growth rate of 10-12% in the next five years. Ongoing research and ...

Thanks to generous support and partnership from Alexandria Real Estate Equities, Inc., Fred Hutch has a new, state-of-the-art ...

The Business Research Company The Business Research Company's Small Molecule Active Pharmaceutical Ingredient Global Market Report 2025 – M ...

While gaps persist in workforce retention, infrastructure, and equitable access, the transformation of Nigeria’s health ...

How can real world evidence (RWE) best be combined with more traditional research methods ... What kinds of partnerships can best help drive innovation in pharma? What makes a good partnership?

The "Biopharmaceutical Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ResearchAndMarkets.com's offering.The Global Biopharmaceutical ...